Literature DB >> 23897

Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis.

R Cameron, J Kellen, A Kolin, A Malkin, E Farber.   

Abstract

The activity of gamma-glutamyltransferase, as measured quantitatively and by histochemical staining, was studied in different cell populations during the induction of liver cancer with 2-acetylaminofluorene (2-AAF) or diethylnitrosamine and compared with findings in fetal and in intact and regenerating adult liver. The enzyme activity is 20-fold higher in 12-week nodules than in control livers and 30-fold higher in 20-week nodules than in controls. A similar 30-fold increase in activity relative to control is present in hepatomas, induced by either 2-AAF or diethylnitrosamine, and in fetal hepatocytes. The enzyme shows increases in activity in foci of very early putative preneoplastic hepatocytes induced by a single dose of diethylnitrosamine and selected by low doses of 2-AAF plus partial hepatectomy. By 7 days, the foci show a 4-fold increase in enzyme activity, and by 3 weeks they are 40-fold higher than in the control liver. Histochemically, the foci are strongly positive for gamma-glutamyltransferase, especially in the bile canaliculi. By 21 days, the ductular (oval) cells induced by 2-AAF have disappeared. When stained for the enzyme activity, the foci stand out clearly against the negative background of the liver, allowing easy quantitation. It appears that gamma-glutamyltransferase is a useful marker for preneoplastic hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 23897

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  A bipartite suppressor: conjunction of two distinct factor-binding sites is essential for down-regulation in rat epoxide hydrolase gene expression.

Authors:  S Kondo; Y Chou; P N Gertson; K Yokoyama; K Itakura
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  The first normal oral mucosa epithelium in which gamma-glutamyl transpeptidase activity has been detected.

Authors:  A E Schwint; A M Collet; A E Mendez; R L Cabrini; M E Itoiz
Journal:  Histochem J       Date:  1992-12

3.  Nuclear factor I-C regulates TGF-{beta}-dependent hair follicle cycling.

Authors:  Genta Plasari; Simone Edelmann; Florence Högger; Yves Dusserre; Nicolas Mermod; Alessandra Calabrese
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

4.  Regulation of mouse mammary-gland gamma-glutamyltranspeptidase mRNA during pregnancy, lactation and weaning.

Authors:  S Siegrist; Y Laperche; M N Chobert; F Bulle; H L Nakhasi; G Guellaën
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

5.  A method for the comparative study of replicative DNA synthesis in GGT-positive and GGT-negative hepatocytes in primary culture isolated from carcinogen-treated rats.

Authors:  Y H Xu; G L Sattler; H C Pitot
Journal:  In Vitro Cell Dev Biol       Date:  1988-10

6.  Effect of hydrocortisone and nicotinamide on gamma glutamyltransferase in primary cultures of rat hepatocytes.

Authors:  M R Rosenberg; S C Strom; G Michalopoulos
Journal:  In Vitro       Date:  1982-09

7.  A fluorometric assay for gamma-glutamyl transpeptidase: demonstration enzymatic activity in cultured cells of neural origin.

Authors:  H D Shine; L Hertz; J De Vellis; B Haber
Journal:  Neurochem Res       Date:  1981-04       Impact factor: 3.996

Review 8.  gamma-Glutamyltranspeptidase: a tumour cell marker with a pharmacological function.

Authors:  M Vanderlaan; W Phares
Journal:  Histochem J       Date:  1981-09

9.  Glutathione and GSH-dependent enzymes in the human gastric mucosa.

Authors:  R Hoppenkamps; E Thies; M Younes; C P Siegers
Journal:  Klin Wochenschr       Date:  1984-02-15

10.  Glutathione and GSH-dependent enzymes in the tumorous and nontumorous mucosa of the human colon and rectum.

Authors:  C P Siegers; H Böse-Younes; E Thies; R Hoppenkamps; M Younes
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.